Rare diseases
Investigational molecules
Locations
Back to Finland385 clinical trials in Espoo, Finland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FinlandKliinisetTutkimukset.fi(opens in a new tab)Study Comparing BI 907828 and Doxorubicin for Patients with Advanced Dedifferentiated Liposarcoma
FinlandStudy of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older
FinlandStudy on the Effect of Allopurinol and Hypothermia for Newborns with Hypoxic-Ischemic Encephalopathy
FinlandStudy Comparing Rituximab with Ibrutinib to Rituximab with Chemotherapy for Older Patients with Untreated Mantle Cell Lymphoma
FinlandStudy on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases
FinlandStudy on the Effectiveness and Safety of BAY 2927088 Compared to Standard Treatment in Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
FinlandStudy on the Effect of Extending Imatinib Treatment from Three to Five Years for Patients with High-Risk Gastrointestinal Stromal Tumor (GIST)
FinlandStudy on the Effectiveness of Fremanezumab for Preventing Migraines in Children and Teens Aged 6 to 17
FinlandStudy of tovorafenib versus standard chemotherapy as first treatment for children with low-grade glioma with RAF gene changes
FinlandStudy comparing tenecteplase and acetylsalicylic acid in patients with central retinal artery occlusion within 4.
FinlandStudy of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation
FinlandStudy of Epcoritamab for Patients with Relapsed, Progressive, or Refractory B-Cell Lymphoma
FinlandThe busiest research cities in the country
What the registry says about research in the country
Comprehensive research focusing on vaccine development for multiple respiratory viruses, including studies of new formulations against influenza, RSV, and pneumococcal infections. Clinical trials are evaluating innovative immunization approaches for various age groups.
Particular emphasis on protecting vulnerable populations such as infants, toddlers, and adults over 60 years old.
Advanced research in cardiovascular medicine, focusing on preventing stroke in atrial fibrillation patients and developing new treatments for acute myocardial infarction. Studies include innovative drug therapies and preventive measures.
Trials are investigating new anticoagulants and emergency interventions for heart conditions.
Innovative research in surgical procedures and specialized medical conditions, including studies on frostbite treatment, plastic surgery outcomes, and post-operative care protocols.
Focus on improving surgical outcomes and developing better treatment protocols for specialized conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
